Fadel E. Ruiz, MD, FAAP
- Pulmonary Medicine

Pediatric Pulmonologist
Assistant Professor, Pediatrics, Pulmonary, Baylor College of Medicine
Medical Director, Baylor Cystic Fibrosis Center
Phone:
832-822-3300
Medical Center
Phone:
281-494-7010
Sugar Land
Languages: English
Departments:
Office locations:
Texas Medical Center
6701 Fannin Street
Houston, TX 77030
15400 Southwest Freeway Sugar Land
Suite 100, 200, 310
Sugar Land, TX 77478
Get to know Fadel E. Ruiz, MD, FAAP
Dr. Ruiz's two major interests are in the area of Cystic Fibrosis and Pediatric Pulmonary Hypertension. He has participated in several studies sponsored by the Cystic Fibrosis Therapeutic Development Network. He actively participates in multiple clinical trials related to Cystic Fibrosis. He is also the principal investigator in several clinical trials studying the use of vasodilator therapies for the treatment of Pulmonary Hypertension in Children.
Education
School | Education | Degree | Year |
---|---|---|---|
University of Alabama at Birmingham | Fellowship | Pediatric Pulmonary | 1998 |
University of South Alabama College of Medicine | Residency | Pediatrics | 1995 |
Universidad Francisco Marroquin-Guatemala | Medical School | Doctor of Medicine | 1991 |
Organizations
Organization Name | Role |
---|---|
American Academy of Pediatrics | Member |
American Thoracic Society | Member |
Asociacion Latino Americana del Torax | Member |
Pulmonary Vascular Research Institute | Member |
Harris County Medical Society | Member |
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Reviews
Cystic Fibrosis Lung Transplant Recipients 10 years of age or Younger: Predisposing Factors for End-stage Disease. Melicoff E, Ruiz FE, Hosek K, Mallory GB. Pediatr Pulmonol. 2022 Mar 3. doi: 10.1002/ppul.25882. Online ahead of print.PMID: 35243829.
Opportunities and challenges of pharmacotherapy for pulmonary arterial hypertension in children. Kam CW, Ruiz FE. Pediatr Pulmonol. 2021 Mar;56(3):593-613. doi: 10.1002/ppul.25101. Epub 2020 Oct 12.PMID: 33002306.